Dr. Carol Ann Labate

DMD | Dentist



  
  908 Penn Ave, Wyomissing
  Pennsylvania, 19610

  610-376-2805    610-376-8822 Maps & Directions
Dr. Carol Ann Labate is a Wyomissing, Pennsylvania based Dentist who is specialized in Dentistry. She may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. Her current practice location is 908 Penn Ave, Wyomissing. Patients can reach her at 610-376-2805.
Dr. Carol Ann Labate is the primary dental care provider for patients of all ages. She is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Carol Ann Labate speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Carol Ann Labate
Specialization: Dentist
Gender:Female
Credentials: DMD
Accepts Medicare Assignment:May Accept
Practice Address:908 Penn Ave, Wyomissing,
Pennsylvania, 19610
Phone:610-376-2805
Fax:610-376-8822
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 0345532289
Enrollment ID: I20160713000768
NPI Number: 1811004039
NPI Enumeration Date: 24 Aug, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 908 Penn Ave,
Wyomissing, Pennsylvania
Zip: 19610
Phone Number: 610-376-2805
Fax Number: 610-376-8822
Patients can reach Dr. Carol Ann Labate at 908 Penn Ave, Wyomissing, Pennsylvania or can call to book an appointment on 610-376-2805. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 13 May, 2024.

Comments/ Reviews: